The FDA approval addresses acquired endocrine resistance by allowing eligible patients with HR-positive, HER2-negative advanced breast cancer to switch to camizestrant when an ESR1 mutation is detected in...
A large batch of ultrasound transmission gel from Pharmaceutical Innovations Inc. in Newark, NJ has been seized in response to an FDA warning that the gel contained dangerous bacteria.
